Aspirin
- Generic Name
- Aspirin
- Brand Names
- Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8O4
- CAS Number
- 50-78-2
- Unique Ingredient Identifier
- R16CO5Y76E
- Background
Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...
- Indication
Pain, fever, and inflammation
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
- Associated Therapies
- Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2012-06-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 39876
- Registration Number
- NCT00000479
Asymptomatic Carotid Artery Plaque Study (ACAPS)
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
Phase 3
Completed
- Conditions
Physicians' Health Study
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT00000500
Randomized Trial of Beta-Carotene and Macular Degeneration
Phase 3
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000152
Randomized Trials of Vitamin Supplements and Eye Disease
Phase 3
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000161
Randomized Trial of Aspirin and Cataracts in U.S. Physicians
Phase 3
Terminated
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000157
Early Treatment Diabetic Retinopathy Study (ETDRS)
Phase 3
Completed
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2006-09-04
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000151
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath